$QSJC
Tancheng Group Co Ltd

2023 Q3 Form 10-Q Financial Statement

#000168316823005661 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $626.0K $854.1K $0.00
YoY Change
Cost Of Revenue $458.4K $737.5K
YoY Change 242.34% 345.05%
Gross Profit $167.6K $116.6K
YoY Change 770.78% 297.87%
Gross Profit Margin 26.77% 13.65%
Selling, General & Admin $145.0K $128.3K $29.28K
YoY Change 874.9% 823.62% 45.38%
% of Gross Profit 86.5% 110.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.781K $4.631K $0.00
YoY Change 653.44%
% of Gross Profit 4.05% 3.97%
Operating Expenses $145.0K $128.3K $29.28K
YoY Change 819.26% 823.62% 45.37%
Operating Profit $22.62K -$11.69K -$29.28K
YoY Change -165.17% -57.24% 45.37%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $23.03K -$11.28K -$29.28K
YoY Change -246.04% -18.83% 45.38%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $23.03K -$11.28K -$29.28K
YoY Change -246.04% -18.83% 45.37%
Net Earnings / Revenue 3.68% -1.32%
Basic Earnings Per Share $0.01 $0.00 -$0.01
Diluted Earnings Per Share $0.01 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 4.382M shares 4.382M shares 4.382M shares
Diluted Shares Outstanding 4.382M shares 4.382M shares 4.382M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.890K
YoY Change 440.0%
Cash & Equivalents $463.0K $1.136M $1.889K
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory $1.195M $1.088M $671.7K
Prepaid Expenses
Receivables
Other Receivables $711.00 $5.360K $477.00
Total Short-Term Assets $3.348M $3.982M $1.889K
YoY Change 129563.67% 1592731.2% 98.84%
LONG-TERM ASSETS
Property, Plant & Equipment $128.1K $135.1K $0.00
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $128.1K $135.1K $0.00
YoY Change 507.68% 744.61%
TOTAL ASSETS
Total Short-Term Assets $3.348M $3.982M $1.889K
Total Long-Term Assets $128.1K $135.1K $0.00
Total Assets $3.476M $4.117M $1.889K
YoY Change 14587.9% 25236.71% 98.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $152.4K $466.8K $85.21K
YoY Change 2443.89%
Accrued Expenses $68.40K
YoY Change 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.586M $5.249M $153.6K
YoY Change 3038.31% 4170.31% 92.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.586M $5.249M $153.6K
Total Long-Term Liabilities $0.00
Total Liabilities $4.586M $5.249M $153.6K
YoY Change 3038.31% 4170.31% 92.43%
SHAREHOLDERS EQUITY
Retained Earnings -$1.349M -$1.372M -$172.9K
YoY Change -1039.62%
Common Stock $4.382K $4.382K $4.381K
YoY Change 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.109M -$1.132M -$151.7K
YoY Change
Total Liabilities & Shareholders Equity $3.476M $4.117M $1.889K
YoY Change 14587.9% 25236.71% 98.84%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income $23.03K -$11.28K -$29.28K
YoY Change -246.04% -18.83% 45.37%
Depreciation, Depletion And Amortization $6.781K $4.631K $0.00
YoY Change 653.44%
Cash From Operating Activities $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00
Net Change In Cash $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001753391
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-228803
dei Entity Registrant Name
EntityRegistrantName
TANCHENG GROUP CO., LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1098668
dei Entity Address Address Line1
EntityAddressAddressLine1
No. 32, Huili Township, Jiaocheng County
dei Entity Address Address Line2
EntityAddressAddressLine2
Lvliang City
dei Entity Address City Or Town
EntityAddressCityOrTown
Shanxi Province
dei Entity Address Country
EntityAddressCountry
CN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
030500
dei Country Region
CountryRegion
86
dei City Area Code
CityAreaCode
139
dei Local Phone Number
LocalPhoneNumber
1097-2765
dei Entity Information Former Legal Or Registered Name
EntityInformationFormerLegalOrRegisteredName
N/A
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4381550 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136410 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71207 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5360 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
477 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1087786 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
671691 usd
CY2023Q2 BIGN Advance To Suppliers
AdvanceToSuppliers
93333 usd
CY2022Q4 BIGN Advance To Suppliers
AdvanceToSuppliers
22347 usd
CY2023Q2 BIGN Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1659189 usd
CY2022Q4 BIGN Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1697452 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3982078 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2463174 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
135138 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
135138 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2023Q2 us-gaap Assets
Assets
4117216 usd
CY2022Q4 us-gaap Assets
Assets
2463174 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
466830 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 usd
CY2023Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
11766 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
35294 usd
CY2023Q2 BIGN Customers Advances Current
CustomersAdvancesCurrent
538347 usd
CY2022Q4 BIGN Customers Advances Current
CustomersAdvancesCurrent
0 usd
CY2023Q2 BIGN Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
4232554 usd
CY2022Q4 BIGN Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
3357789 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5249497 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3393083 usd
CY2023Q2 us-gaap Liabilities
Liabilities
5249497 usd
CY2022Q4 us-gaap Liabilities
Liabilities
3393083 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4381550 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4381550 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
4382 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4382 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
72594 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
26405 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1372121 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1123560 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132281 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-929909 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4117216 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2463174 usd
CY2023Q2 us-gaap Revenues
Revenues
854097 usd
CY2022Q2 us-gaap Revenues
Revenues
195018 usd
us-gaap Revenues
Revenues
1200716 usd
us-gaap Revenues
Revenues
237440 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
737498 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
165712 usd
us-gaap Cost Of Revenue
CostOfRevenue
1047704 usd
us-gaap Cost Of Revenue
CostOfRevenue
204307 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
116599 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
29306 usd
us-gaap Gross Profit
GrossProfit
153012 usd
us-gaap Gross Profit
GrossProfit
33133 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6956 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14657 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14028 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15775 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
121335 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41991 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
388040 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
59708 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
128291 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
56648 usd
us-gaap Operating Expenses
OperatingExpenses
402068 usd
us-gaap Operating Expenses
OperatingExpenses
75483 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11692 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27342 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-249056 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-42350 usd
CY2023Q2 us-gaap Other Income
OtherIncome
417 usd
CY2022Q2 us-gaap Other Income
OtherIncome
101 usd
us-gaap Other Income
OtherIncome
495 usd
us-gaap Other Income
OtherIncome
434 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11275 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27241 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-248561 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41916 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11275 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-27241 usd
us-gaap Net Income Loss
NetIncomeLoss
-248561 usd
us-gaap Net Income Loss
NetIncomeLoss
-41916 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51160 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1238 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
46189 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1210 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
39885 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26003 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-202372 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40706 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.006
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.057
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.057
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.010
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.010
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-92289 usd
us-gaap Net Income Loss
NetIncomeLoss
-41916 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1210 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-132995 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-929909 usd
us-gaap Net Income Loss
NetIncomeLoss
-248561 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
46189 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132281 usd
us-gaap Profit Loss
ProfitLoss
-248561 usd
us-gaap Profit Loss
ProfitLoss
-41916 usd
us-gaap Depreciation
Depreciation
4631 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
5142 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
438 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
469517 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-174098 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
75507 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
181360 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
489246 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
386 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-22935 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
34270 usd
BIGN Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
564196 usd
BIGN Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
-104387 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
44412 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
1512495 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
191999 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1631842 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
146258 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-146258 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1074151 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1282566 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1074151 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1282566 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-54689 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-12111 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1065203 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-361387 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71207 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
466315 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1136410 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104928 usd
us-gaap Net Income Loss
NetIncomeLoss
-248561 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1132281 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zJpDnCn0Z543" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(c) <span id="xdx_86E_zf3upQpeme68">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent liabilities at the balance sheet date, and revenue and expenses in the financial statements and accompanying notes. Significant accounting estimates reflected in the Company’s consolidated financial statements include economic lives and impairment of property, plant and equipment and allowance for doubtful accounts. Actual results could differ from those estimates and such differences could affect the results of operations reported in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11275 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27241 usd
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023Q2 us-gaap Income Tax Reconciliation Tax Holidays
IncomeTaxReconciliationTaxHolidays
2819 usd
CY2022Q2 us-gaap Income Tax Reconciliation Tax Holidays
IncomeTaxReconciliationTaxHolidays
6810 usd
CY2023Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
2819 usd
CY2022Q2 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
6810 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zZeYvRbi9gk7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>(l)</b></span> <span style="font-size: 10pt"><b><span id="xdx_862_zj5uKphim5U2">Concentration of credit risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents and other receivables. As of June 30, 2023 and December 31, 2022, substantially all of the Company’s cash and cash equivalents were deposited with financial institutions with high-credit ratings and quality. During the three and six months ended June 30, 2023 and 2022, revenue amounting to $<span id="xdx_908_eus-gaap--Revenues_c20230401__20230630__srt--TitleOfIndividualAxis__custom--ThirdPartiesMember_zkxliE24YI2a" title="Revenue">854,097</span>, $, $<span id="xdx_903_eus-gaap--Revenues_c20220401__20220630__srt--TitleOfIndividualAxis__custom--ThirdPartiesMember_zcIsXYPhUpRk" title="Revenue">60,931</span>, $<span id="xdx_90F_eus-gaap--Revenues_c20230101__20230630__srt--TitleOfIndividualAxis__custom--ThirdPartiesMember_z8hoj2iOdrVf" title="Revenue">1,200,716</span> and $<span id="xdx_90E_eus-gaap--Revenues_c20220101__20220630__srt--TitleOfIndividualAxis__custom--ThirdPartiesMember_zA3qKF5cQkwk" title="Revenue">103,353</span> were generated from third parties, respectively; and $nil<span id="xdx_90B_eus-gaap--Revenues_c20230401__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z1rOk8xPmCAg" style="display: none" title="Revenue">0</span>, $<span id="xdx_901_eus-gaap--Revenues_c20220401__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zBpfDr93XQKa" title="Revenue">134,087</span>, $nil<span id="xdx_908_eus-gaap--Revenues_c20230101__20230630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zFp0WbqwgkQ" style="display: none" title="Revenue">0</span> and $<span id="xdx_901_eus-gaap--Revenues_c20220101__20220630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zj1Al1TE2nG1" title="Revenue">134,087</span> were generated from a related party (see Note 7), respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Details of customers who accounted for 10% or more of the Company’s total revenue for the three and six months ended June 30, 2023 and 2022 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zYvyFiaobmt3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Concentration of Risk)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B9_zapqyeMb3eZ4" style="display: none">Schedule of concentration of credit risk</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%; text-align: justify">Jiaocheng Xinmu Trade Co., Ltd</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230401__20230630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember_zIUjELXvKQy1" style="width: 13%; text-align: right" title="Total revenue">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230401__20230630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z1Omv9H5wcD1" style="width: 13%; text-align: right" title="Total revenue percentage">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220401__20220630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember_znANnsdYLqh8" style="width: 13%; text-align: right" title="Total revenue">134,087</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zR0pZsNgbEA4" title="Total revenue percentage">68</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Customer A</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630__srt--MajorCustomersAxis__custom--CustomerAMember_zT27quPzm9N8" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">115,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zyXkYUCH8fFa" title="Total revenue percentage">13</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220401__20220630__srt--MajorCustomersAxis__custom--CustomerAMember_zsa7yLOuEw7a" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220401__20220630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zzqWKKNo904j" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue percentage">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230401__20230630_zsrdAiCFEkUe" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">115,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98C_eus-gaap--ConcentrationRiskPercentage1_dp_c20230401__20230630__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zCewJwczaej4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue percentage">13%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220401__20220630_zjXpARjeDCvh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">134,087</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20220401__20220630__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z8CeIeAoCq8h" title="Total revenue percentage">68</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Concentration of Risk 1)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the six months ended June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 32%; text-align: justify">Jiaocheng Xinmu Trade Co., Ltd</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230101__20230630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember_zjjxQ0MR3402" style="width: 13%; text-align: right" title="Total revenue">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230101__20230630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zik3IQoUtIvb" style="width: 13%; text-align: right" title="Total revenue percentage">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220101__20220630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember_zoWVzjte1tEb" style="width: 13%; text-align: right" title="Total revenue">134,087</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--JiaochengXinmuTradeCoLtdMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_ztTkr5F31CU9" title="Total revenue percentage">56</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Customer A</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerAMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">115,073</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z1WlWhwjxcF1" title="Total revenue percentage">10</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerAMember_zbWZcKmxsekj" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ConcentrationRiskPercentage1_dp0_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z6zCD8Faw1C9" style="border-bottom: Black 1pt solid; text-align: right" title="Total revenue percentage">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20230101__20230630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">115,073</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_983_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zIwqDyzwKHBc" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue percentage">10%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20220630_zCQlIo7eIG3k" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenue">134,087</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--TotalCustomersMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_ziU4se1Xyam5" title="Total revenue percentage">56</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zi6GCdZvmho8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115073 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
134087 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
115073 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
134087 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1087786 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
671691 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
CY2023Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
CY2022Q2 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
CY2023Q2 BIGN Prepayments
Prepayments
5360 usd
CY2022Q4 BIGN Prepayments
Prepayments
477 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
0 usd
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
0 usd
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5360 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
477 usd
CY2023Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
436752 usd
CY2023Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.25 pure
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.25 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-248561 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41916 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
us-gaap Income Tax Reconciliation Tax Holidays
IncomeTaxReconciliationTaxHolidays
62140 usd
us-gaap Income Tax Reconciliation Tax Holidays
IncomeTaxReconciliationTaxHolidays
10479 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
62140 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
10479 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.03 pure
BIGN Vat Rate
VatRate
0.01 pure
BIGN Vat Rate
VatRate
0.01 pure
CY2023Q2 BIGN Vat Rate
VatRate
0.01 pure
CY2022Q2 BIGN Vat Rate
VatRate
0.01 pure
CY2023Q2 BIGN Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1659189 usd
CY2022Q4 BIGN Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1697452 usd
CY2023Q2 BIGN Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
4232554 usd
CY2022Q4 BIGN Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
3357789 usd
CY2022Q3 us-gaap Other Liabilities
OtherLiabilities
146114 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16750 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2023Q2 BIGN Reserve Requires Annual Rate
ReserveRequiresAnnualRate
0.10 pure
CY2023Q2 us-gaap Contractual Obligation
ContractualObligation
0 usd

Files In Submission

Name View Source Status
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
0001683168-23-005661-index-headers.html Edgar Link pending
0001683168-23-005661-index.html Edgar Link pending
0001683168-23-005661.txt Edgar Link pending
0001683168-23-005661-xbrl.zip Edgar Link pending
bign-20230630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
bign-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bign-20230630_def.xml Edgar Link unprocessable
bign-20230630_pre.xml Edgar Link unprocessable
bign-20230630_lab.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tancheng_ex3101.htm Edgar Link pending
tancheng_ex3201.htm Edgar Link pending
tancheng_i10q-063023.htm Edgar Link pending
tancheng_i10q-063023_htm.xml Edgar Link completed